Related Experiment Video
Updated: Feb 23, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control
Cristina V Cardemil1, Rebecca M Dahl1, Lisa James1
1From the Centers for Disease Control and Prevention, Atlanta (C.V.C., K.W., H.E.G., M.S., M.M., D.R.F., M.P.); Maximus Federal, Falls Church, VA (R.M.D.); and the University of Iowa (L.J.) and Johnson County Public Health (J.R.), Iowa City, and the Iowa Department of Public Health, Des Moines (P.Q.).
Background:
The effect of a third dose of the measles-mumps-rubella (MMR) vaccine in stemming a mumps outbreak is unknown. During an outbreak among vaccinated students at the University of Iowa, health officials implemented a widespread MMR vaccine campaign. We evaluated the effectiveness of a third dose for outbreak control and assessed for waning immunity.
Methods:
Of 20,496 university students who were enrolled during the 2015-2016 academic year, mumps was diagnosed in 259 students. We used Fisher's exact test to compare unadjusted attack rates according to dose status and years since receipt of the second MMR vaccine dose. We used multivariable time-dependent Cox regression models to evaluate vaccine effectiveness, according to dose status (three vs. two doses and two vs. no doses) after adjustment for the number of years since the second dose.
Results:
Before the outbreak, 98.1% of the students had received at least two doses of MMR vaccine. During the outbreak, 4783 received a third dose. The attack rate was lower among the students who had received three doses than among those who had received two doses (6.7 vs. 14.5 cases per 1000 population, P<0.001). Students had more than nine times the risk of mumps if they had received the second MMR dose 13 years or more before the outbreak. At 28 days after vaccination, receipt of the third vaccine dose was associated with a 78.1% lower risk of mumps than receipt of a second dose (adjusted hazard ratio, 0.22; 95% confidence interval, 0.12 to 0.39). The vaccine effectiveness of two doses versus no doses was lower among students with more distant receipt of the second vaccine dose.
Conclusions:
Students who had received a third dose of MMR vaccine had a lower risk of mumps than did those who had received two doses, after adjustment for the number of years since the second dose. Students who had received a second dose of MMR vaccine 13 years or more before the outbreak had an increased risk of mumps. These findings suggest that the campaign to administer a third dose of MMR vaccine improved mumps outbreak control and that waning immunity probably contributed to propagation of the outbreak. (Funded by the Centers for Disease Control and Prevention.).
Insights
A third dose of the measles-mumps-rubella (MMR) vaccine significantly reduced mumps risk during an outbreak among vaccinated students. Waning immunity contributed to the outbreak, highlighting the importance of booster vaccinations.
Area of Science:
- Epidemiology
- Immunology
- Public Health
Background:
- Mumps outbreaks can occur even in highly vaccinated populations.
- The effectiveness of a third measles-mumps-rubella (MMR) vaccine dose in controlling outbreaks was previously unknown.
- Waning immunity may play a role in vaccine effectiveness over time.
Purpose of the Study:
- To evaluate the effectiveness of a third MMR vaccine dose in controlling a mumps outbreak.
- To assess the impact of waning immunity on mumps risk.
- To analyze mumps attack rates based on vaccination status and time since vaccination.
Main Methods:
- Retrospective cohort study of university students during a mumps outbreak.
- Comparison of mumps attack rates between students who received two vs. three MMR vaccine doses.
- Multivariable Cox regression models to assess vaccine effectiveness, adjusting for time since the second dose.
Main Results:
- The attack rate was significantly lower in students who received three MMR doses compared to two doses (6.7 vs. 14.5 cases per 1000).
- Students vaccinated 13 or more years prior had over nine times the risk of mumps.
- A third MMR dose was associated with a 78.1% lower risk of mumps compared to a second dose.
Conclusions:
- A third MMR vaccine dose effectively controlled the mumps outbreak.
- Waning immunity is a likely factor in the propagation of mumps outbreaks.
- Booster MMR vaccination strategies may be necessary for sustained mumps control.
More Related Videos
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Related Concept Videos
Vaccinations
Myocarditis III: Medical Management